Annual Drug Patent Expirations for RADICAVA
Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has seven patent family members in six countries.
The generic ingredient in RADICAVA is edaravone. One supplier is listed for this compound. Additional details are available on the edaravone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
